These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7688411)

  • 21. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
    Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
    Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the antigenic evolution of field isolates using the reverse genetics system of infectious bursal disease virus (IBDV).
    Durairaj V; Sellers HS; Linnemann EG; Icard AH; Mundt E
    Arch Virol; 2011 Oct; 156(10):1717-28. PubMed ID: 21667192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of sequence changes responsible for the attenuation of highly virulent infectious bursal disease virus.
    Yamaguchi T; Ogawa M; Inoshima Y; Miyoshi M; Fukushi H; Hirai K
    Virology; 1996 Sep; 223(1):219-23. PubMed ID: 8806555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence and phylogenetic analysis of the VP2 gene of very virulent infectious bursal disease virus isolates.
    Hoque MM; Omar AR; Hair-Bejo M; Aini I
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):93-9. PubMed ID: 12186763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping.
    Wang XN; Zhang GP; Zhou JY; Feng CH; Yang YY; Li QM; Guo JQ; Qiao HX; Xi J; Zhao D; Xing GX; Wang ZL; Wang SH; Xiao ZJ; Li XW; Deng RG
    Viral Immunol; 2005; 18(3):549-57. PubMed ID: 16212534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
    Pierce CM; Rossitto PV; MacLachlan NJ
    Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.
    Reddy SK; Silim A; Ratcliffe MJ
    Arch Virol; 1992; 127(1-4):209-22. PubMed ID: 1333752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7.
    Lazdins I; Coulson BS; Kirkwood C; Dyall-Smith M; Masendycz PJ; Sonza S; Holmes IH
    Virology; 1995 May; 209(1):80-9. PubMed ID: 7747487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic properties of porcine teschovirus 1 (PTV-1) Talfan strain and molecular strategy for serotyping of PTVs.
    Kaku Y; Murakami Y; Sarai A; Wang Y; Ohashi S; Sakamoto K
    Arch Virol; 2007; 152(5):929-40. PubMed ID: 17265104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time reverse transcriptase-polymerase chain reaction detection and analysis of nucleotide sequences coding for a neutralizing epitope on infectious bursal disease viruses.
    Jackwood DJ; Spalding BD; Sommer SE
    Avian Dis; 2003; 47(3):738-44. PubMed ID: 14562905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses.
    Eterradossi N; Arnauld C; Toquin D; Rivallan G
    Arch Virol; 1998; 143(8):1627-36. PubMed ID: 9739340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens.
    Vakharia VN; Snyder DB; He J; Edwards GH; Savage PK; Mengel-Whereat SA
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1201-6. PubMed ID: 8389805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
    Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
    Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue of infectious bursal disease virus from mosaic full-length clones composed of serotype I and II cDNA.
    Boot HJ; ter Huurne AA; Vastenhouw SA; Kant A; Peeters BP; Gielkens AL
    Arch Virol; 2001 Oct; 146(10):1991-2007. PubMed ID: 11722019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of the VP2 variable region of the gene from infectious bursal disease virus isolates].
    Shcherbakova LO; Lomakin AI; Borisov AV; Drygin VV; Gusev AA
    Mol Gen Mikrobiol Virusol; 1998; (1):35-40. PubMed ID: 9511141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
    Kobayashi N; Taniguchi K; Urasawa S
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.